Safety

Octreotide

Adverse-event report summary for Octreotide, drawn from the FDA Adverse Event Reporting System (FAERS).

Total reports
7,831
Reports flagged serious
6,737

“Serious” is FAERS’s own report-level flag (e.g. death, hospitalization, or another outcome the reporter marked as serious) and does not indicate a verified or compound-caused outcome.

Most frequently reported reactions

  1. Off Label Use848 reports
  2. Diarrhoea832 reports
  3. Drug Ineffective810 reports
  4. Death575 reports
  5. Nausea569 reports
  6. Fatigue507 reports
  7. Abdominal Pain404 reports
  8. Malignant Neoplasm Progression382 reports
  9. Vomiting334 reports
  10. Product Use In Unapproved Indication319 reports
  11. Dyspnoea297 reports
  12. Weight Decreased297 reports
  13. Pain286 reports
  14. Asthenia281 reports
  15. Headache267 reports

Counts reflect the most-reported reaction terms (MedDRA preferred terms) associated with reports naming this compound. A single report can list multiple reactions, so reaction counts need not sum to the total number of reports.